Clinical Trial Update: Tocilizumab in Lung Transplantation [Phase 2]

View source ↗

Summary

This update announces a Phase 2 trial of tocilizumab in lung transplantation, currently recruiting under NIAID sponsorship.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplantation

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lung Transplant | Phase 2 | Status: RECRUITING